Verrica Pharmaceuticals Inc. - COM (VRCA)

Historical Portfolio Holders from Q2 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
17.6 M
Holdings value Q1 2024
$104 M
Value change Q1 2024
-$1.51 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
59
Number of buys Q1 2024
17
Number of sells Q1 2024
-27
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
92511W108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 17.6 M $104 M -$1.51 M $5.92 59
2023 Q4 17.9 M $131 M +$23.8 M $7.32 61
2023 Q3 15 M $58.4 M +$1.49 M $3.89 65
2023 Q2 14.6 M $84.2 M +$9.11 M $5.77 63
2023 Q1 12.9 M $84 M +$15 M $6.50 58
2022 Q4 10.8 M $29.7 M -$1.57 M $2.75 47
2022 Q3 10.2 M $29.9 M -$2.47 M $2.92 44
2022 Q2 11.2 M $21.5 M +$4.53 M $1.92 49
2022 Q1 8.78 M $71.2 M -$774 K $8.11 44
2021 Q4 8.95 M $82 M -$7.32 M $9.16 41
2021 Q3 9.17 M $115 M -$8.45 M $12.50 48
2021 Q2 9.94 M $112 M -$1.69 M $11.30 52
2021 Q1 9.93 M $150 M +$15 M $15.15 50
2020 Q4 8.93 M $103 M -$552 K $11.51 41
2020 Q3 8.87 M $68.7 M +$715 K $7.74 40
2020 Q2 8.21 M $90.4 M -$417 K $11.01 41
2020 Q1 8.25 M $90.1 M -$4.84 M $10.93 42
2019 Q4 9.19 M $144 M -$4.19 M $15.89 48
2019 Q3 9.26 M $137 M +$4.28 M $14.76 40
2019 Q2 9.02 M $105 M +$2.57 M $11.62 38
2019 Q1 8.8 M $96.8 M +$5.63 M $10.81 37
2018 Q4 8.44 M $68.8 M -$1.84 M $8.15 39
2018 Q3 8.24 M $134 M -$359 K $16.25 44
2018 Q2 8.31 M $162 M +$162 M $19.73 28